Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of complicated skin or skin structure infection~* Male or female, 18 years or older~* Need for intravenous treatment for 4 to 14 days~Exclusion Criteria:~* Skin infection that can be treated by surgery \& wound care alone~* Diabetic foot ulcers or bedsores where the infection is present longer than 1 week~* Poor circulation such that amputation of the infected site is likely within a month Other exclusions apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Arm 1: Tigecycline
- 2 (Type: ACTIVE_COMPARATOR): Arm 2: Ampicillin-Sulbactam or Amoxicillin-Clavulanate plus or minus a glycopeptide

Based on this trial design, predict the completion outcome and termination type (if applicable).